Collaboration Agreements
All Business Industries
IDEAYA Biosciences, Inc. (52) | Collaboration Agreements (9)
- Clinical Trial Collaboration and Supply Agreement by and between Amgen Inc. and IDEAYA Biosciences, Inc. made as of July 26, 2022 (Filed With SEC on November 8, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Third Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of March 9, 2022. (Second Pfizer Agreement) (Filed With SEC on May 10, 2022)
- Amendment No. 2 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. effective as of January... (Filed With SEC on May 10, 2022)
- Amendment No. 1 to Collaboration, Option and License Agreement between GlaxoSmithKline Intellectual Property (No. 4) Limited and IDEAYA Biosciences, Inc. dated as of October 23,... (Filed With SEC on March 18, 2022)
- Amendment No. 3 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of August 9, 2021 (Filed With SEC on November 15, 2021)
- Amendment No. 2 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of April 8, 2021 (Filed With SEC on May 10, 2021)
- Amendment No. 1 to Clinical Trial Collaboration and Supply Agreement between Pfizer Inc. and IDEAYA Biosciences, Inc. dated as of September 23, 2020 (Filed With SEC on November 12, 2020)
- Clinical Trial Collaboration and Supply Agreement between IDEAYA Biosciences, Inc. and Pfizer Inc. dated as of March 11, 2020 (Filed With SEC on May 12, 2020)